Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 55%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health demonstrated a robust financial performance, with gross profit reaching $269.0 million, reflecting an 8% year-over-year increase that exceeded expectations. The company’s chronic therapy business recorded growth exceeding 10%, contributing to a positive trend in revenue generation. Furthermore, Option Care Health raised its 2025 revenue estimate to $5.61 billion, anticipating a 12% year-over-year growth, alongside an upward adjustment in its overall financial guidance.

Bears say

Option Care Health Inc. faces challenges with its general and administrative (G&A) expenses, which are expected to decline slowly relative to revenue, potentially impacting profitability. The company encounters significant revenue dependency, as its largest customer accounted for 14% of its 2023 revenue, making it vulnerable to substantial financial repercussions should it lose this client. Additionally, the anticipated gross profit headwind related to Stelara, estimated at over $20 million for the quarter, poses further risks to EBITDA margin expansion amid a shift toward lower-margin chronic therapies.

OPCH has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 55% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 11 analysts, OPCH has a Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.